F3 Platform Biologics, Inc. (JDRR)

F3 Platform Biologics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.23	0.3	0.1
Cash & Cash Equivalents	0.23	0.3	0.1
Cash Growth	-	218.28%	-
Receivables	0.03	0.05	0.02
Total Current Assets	0.26	0.35	0.11
Other Long-Term Assets	-	0	0.03
Total Long-Term Assets	-	0	0.03
Total Assets	-	0.35	0.14
Accounts Payable	-	0.07	0.03
Current Debt	-	1.64	2.26
Other Current Liabilities	3.03	1.19	0.88
Total Current Liabilities	3.03	2.89	3.17
Long-Term Debt	-	4.32	3.1
Total Long-Term Liabilities	-	4.32	3.1
Total Liabilities	-	7.21	6.27
Total Debt	5.96	5.96	5.36
Debt Growth	-	11.19%	-
Retained Earnings	-	-13.99	-13.06
Shareholders' Equity	-7.1	-6.86	-6.13
Net Cash / Debt	-5.73	-5.66	-5.27
Working Capital	-2.77	-2.53	-3.06

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).